Atai Beckley N.V
Stock
Stock
ISIN: NL0015000DX5
Ticker: ATAI
NL0015000DX5
ATAI
Price
Price
CHART BY
Frequently asked questions
What is Atai Beckley N.V's market capitalization?
The market capitalization of Atai Beckley N.V is $1.38B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Atai Beckley N.V?
Atai Beckley N.V's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.804. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Atai Beckley N.V's stock?
Currently, 11 analysts cover Atai Beckley N.V's stock, with a consensus target price of $12.11. Analyst ratings provide insights into the stock's expected performance.
What is Atai Beckley N.V's revenue over the trailing twelve months?
Over the trailing twelve months, Atai Beckley N.V reported a revenue of $331.00K.
What is the EBITDA for Atai Beckley N.V?
Atai Beckley N.V's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$105.53M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Atai Beckley N.V?
Atai Beckley N.V has a free cash flow of -$79.86M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Atai Beckley N.V have, and what sector and industry does it belong to?
Atai Beckley N.V employs approximately 54 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Atai Beckley N.V's shares?
The free float of Atai Beckley N.V is 174.80M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.38B
- EPS (TTM)
- -$0.804
- Free Float
- 174.80M
- Revenue (TTM)
- $331.00K
- EBITDA (TTM)
- -$105.53M
- Free Cashflow (TTM)
- -$79.86M
Pricing
- 1D span
- $4.476$4.742
- 52W span
- $1.15$6.69
Analyst Ratings
The price target is $12.11 and the stock is covered by 11 analysts.
Buy
11
Hold
0
Sell
0
Information
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
- Employees
- 54
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- NL0015000DX5
- Primary Ticker
- ATAI
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet